Can parkin be a target for future treatment of Parkinson's disease?

Author： Kubo Shin-ichiro   Hatano Taku   Takanashi Masashi   Hattori Nobutaka  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.10, 2013-10, pp. : 1133-1144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The parkin protein as a therapeutic target in Parkinson's disease

By Winklhofer Konstanze F  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1543-1552

Informa Healthcare

Access to resources Recommend Favorite

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 686-700

Bentham Science Publishers

Access to resources Recommend Favorite

Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 670-684

Bentham Science Publishers

Access to resources Recommend Favorite

Safinamide in the treatment of Parkinson's disease

By Schapira Anthony HV  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 13, 2010-09 ,pp. : 2261-2268

Informa Healthcare

Access to resources Recommend Favorite

Istradefylline for the treatment of Parkinson's disease

By Park Ariane   Stacy Mark  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 111-114

Informa Healthcare

Access to resources Recommend Favorite